Autologous Hematopoietic Cell Transplantation in Patients With Multiple Myeloma: Effect of Age

Autologous hematopoietic cell transplantation has been shown to prolong survival in patients with multiple myeloma; however, adequate data are lacking for patients aged> 70 years and   70 vs.  ≤ 50 years). Our study showed comparable outcomes between these 2 age groups.

Source: Clinical Lymphoma, Myeloma and Leukemia - November 23, 2016 Category: Hematology Authors: Binod Dhakal, Ariel Nelson, Guru Subramanian Guru Murthy, Raphael Fraser, Daniel Eastwood, Mehdi Hamadani, Marcello Pasquini, Anita D'Souza, Parameswaran Hari Tags: Original Study Source Type: research